United States:
COVID-19 Implications For The OTC Derivatives Markets
09 June 2020
Kramer Levin Naftalis & Frankel LLP
To print this article, all you need is to be registered or login on Mondaq.com.
Corporate partners Fabien Carruzzo and Gilles Kolifrath,
associates Daniel King, Jeruska Lugo Sánchez and Linda
Sharkey authored a Lexis Practice Advisor article titled
"COVID-19 Implications for the OTC Derivatives Markets"
in May 2020. The article examines a number of issues for market
participants to consider in the event of disruptions and volatility
in the markets.
Read the full article here.
Article originally published on 28 May 2020
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Coronavirus (COVID-19) from United States
Are Your NDAs Up To Date?
Wolf, Greenfield & Sacks, P.C.
Nondisclosure agreements (NDAs) can be used to protect companies' confi dential and trade secret information. But you should resist the urge to have a vendor...
Legal Implications Of New York Times vs. OpenAI
BoyarMiller
The New York Times recently filed a landmark lawsuit against OpenAI and Microsoft, accusing them of copyright infringement in the training of the chatbot ChatGPT which launched just over a year ago.